Drug recall · September 22, 2021
Candesartan Cilexetil Tablets recall
Why: Failed Impurities/Degradation Specifications; out of specification for Related Compound
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Candesartan Cilexetil Tablets, USP 16 mg, 30 count bottles, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 NDC 0378-3231-93
- Lots / codes
Lot # 3107334, exp. date October 2021
- Quantity
- 21,094
- Company
- Viatris, Morgantown, WV
- Distribution
- Product was distributed nationwide.
- Initiated
- September 13, 2021 · Voluntary: Firm initiated
- Classified
- September 14, 2021
- Reported
- September 22, 2021
- Ended
- April 28, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Candesartan
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.